EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating SMRP and CA ‐125 before and after pleurectomy decortication for pleural mesothelioma

Juuso Paajanen iD, Ahmed Sadek, William G Richards, Yue Xie, Emanuele Mazzola, Kristina Sidopoulos, John Kuckelman, Ritu R Gill, Raphael Bueno

Thoracic Cancer · 2024

DOI: 10.1111/1759-7714.15264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2024. Verfasst von Juuso Paajanen und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Thoracic Surgery Oncology Laboratory and the International Mesothelioma Program (http://www.impmeso.org), Division of Thoracic Surgery and the Lu…. Hauptthemen laut MEDLINE: CA-125 Antigen, Pleural Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MedGenome, Serum intuitive, Siemens.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tumor recurrence remains the main barrier to survival after surgery for pleural mesothelioma (PM). Soluble mesothelin‐related protein (SMRP) and cancer antigen 125 (CA‐125) are established blood‐based biomarkers for monitoring PM. We prospectively studied the utility of these biomarkers after pleurectomy decortication (PD).

Methods

Patients who underwent PD and achieved complete macroscopic resection with available preoperative SMRP levels were included. Tumor marker levels were determined within 60 days of three timepoints: (1) preoperation, (2) post‐operation, and (3) recurrence.

Results

Of 356 evaluable patients, 276 (78%) had recurrence by the end of follow‐up interval. Elevated preoperative SMRP levels were associated with epithelioid histology ( p < 0.013), advanced TNM ( p < 0.001) stage, and clinical stage ( p < 0.001). Preoperative CA‐125 levels were not significantly associated with clinical covariates. Neither biomarker was associated with survival or disease‐free survival. With respect to nonpleural and nonlymphatic recurrences, mean SMRP levels were elevated in patients with pleural ( p = 0.021) and lymph node ( p = 0.042) recurrences. CA‐125 levels were significantly higher in patients with abdominal ( p < 0.001) and lymph node ( p = 0.004) recurrences. Among patients with all three timepoints available, we observed an average decrease in SMRP levels by 1.93 nmol/L ( p < 0.001) postoperatively and again an average increase at recurrence by 0.79 nmol/L ( p < 0.001). There were no significant changes in levels of CA‐125 across the study timepoints ( p = 0.47).

Conclusions

Longitudinal changes in SMRP levels corresponded with a radiographic presence of disease in a subset of patients. SMRP surveillance could aid in detection of local recurrences, whereas CA‐125 could be helpful in recognizing abdominal recurrences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CA-125 AntigenPleural NeoplasmsBiomarkers, TumorHumansMaleFemaleAgedMiddle AgedMesotheliomaNeoplasm Recurrence, LocalMesothelinMesothelioma, MalignantProspective StudiesAdultAged, 80 and overGPI-Linked ProteinsLung Neoplasms

Stichwörter der Autor:innen

CA‐125SMRPbiomarkerspleural mesotheliomapleurectomy decortication

Substanzen

CA-125 AntigenBiomarkers, TumorMesothelinGPI-Linked Proteins

Autor:innen und Institutionen

  • The Thoracic Surgery Oncology Laboratory and the International Mesothelioma Program (http://www.impmeso.org), Division of Thoracic Surgery and the Lung Center, Brigham, and Women's Hospital, Harvard Medical School, Bost…
  • Deparment of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Juuso Paajanen

Förderung

  • MedGenome
  • Serum intuitive
  • Siemens
  • Merck
  • Genentech Foundation
  • Roche
  • Bicycles therapeutics
  • Verastem Oncology

Zitieren

APA

Paajanen, J., Sadek, A., Richards, W. G., Xie, Y., Mazzola, E., Sidopoulos, K., Kuckelman, J., Gill, R. R., & Bueno, R. (2024). Circulating SMRP and CA ‐125 before and after pleurectomy decortication for pleural mesothelioma. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15264

Vancouver

Paajanen J, Sadek A, Richards WG, Xie Y, Mazzola E, Sidopoulos K, et al. Circulating SMRP and CA ‐125 before and after pleurectomy decortication for pleural mesothelioma. Thoracic Cancer. 2024. doi:10.1111/1759-7714.15264

BibTeX
@article{Paajanen2024,
  author = {Paajanen, Juuso and Sadek, Ahmed and Richards, William G and Xie, Yue and Mazzola, Emanuele and Sidopoulos, Kristina and Kuckelman, John and Gill, Ritu R and Bueno, Raphael},
  title = {Circulating SMRP and CA ‐125 before and after pleurectomy decortication for pleural mesothelioma},
  journal = {Thoracic Cancer},
  year = {2024},
  doi = {10.1111/1759-7714.15264}
}
Kostenlos starten →